Vitamin D status and metabolic syndrome in the elderly: The Rotterdam Study

European Journal of Endocrinology

Volumn 172, Issue 3, 2015, Pages 327-335

  Vitezova, A ^a   Zillikens, M C ^a   Van Herpt, T T W ^a   Sijbrands, E J G ^a   Hofman, A ^a   Uitterlinden, A G ^a   Franco, O H ^a   Kiefte De Jong, J C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; GLUCOSE BLOOD LEVEL; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; BLOOD; METABOLISM; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; VITAMIN D; WAIST CIRCUMFERENCE;

EID: 84923677665     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0580     Document Type: Article

References (39)

1. Wacker M & Holick MF. Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013 5 111-148. (doi:10.3390/nu5010111)
2. Pramyothin P & Holick MF. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Current Opinion in Gastroenterology 2012 28 139-150. (doi:10.1097/MOG.0b013e32835004dc)
3. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281. (doi:10.1056/NEJMra070553)
4. Awad AB, Alappat L & Valerio M. Vitamin D and metabolic syndrome risk factors: evidence and mechanisms. Critical Reviews in Food Science and Nutrition 2012 52 103-112. (doi:10.1080/10408391003785458)
5. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo- Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS et al. IOM committee members respond to Endocrine Society vitamin D guideline. Journal of Clinical Endocrinology and Metabolism 2012 97 1146-1152. (doi:10.1210/jc.2011-2218)
6. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 1640-1645. (doi:10.1161/CIRCULATIONAHA.109.192644)
7. Khan H, Kunutsor S, Franco OH & Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and metaanalysis of prospective studies. Proceedings of the Nutrition Society 2013 72 89-97. (doi:10.1017/S0029665112002765)
8. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, Clarke A & Franco OH. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010 65 225-236. (doi:10.1016/j.maturitas.2009.12.013)
9. Kong J & Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. American Journal of Physiology. Endocrinology and Metabolism 2006 290 E916-E924. (doi:10.1152/ajpendo.00410.2005)
10. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB & Zhang X. 1,25- Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes/Metabolism Research and Reviews 2008 24 459-464. (doi:10.1002/dmrr.873)
11. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Ebeling PR & Daly RM. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). Journal of Clinical Endocrinology and Metabolism 2012 97 1953-1961. (doi:10.1210/jc.2011-3187)
12. Reis JP, von MuhlenD, Kritz-Silverstein D, Wingard DL & Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence ofmetabolic syndrome in community-dwelling older adults. Diabetes Care 2007 30 1549-1555. (doi:10.2337/dc06-2438)
13. Oosterwerff MM, Eekhoff EM, Heymans MW, Lips P & van Schoor NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clinical Endocrinology 2011 75 608-613. (doi:10.1111/j.1365-2265.2011.04110.x)
14. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH et al. The Rotterdam Study: objectives and design update. European Journal of Epidemiology 2014 28 889-926. (doi:10.1007/ s10654-013-9866-z)
15. van Lee L, Geelen A, van Huysduynen EJ, de Vries JH, van't Veer P & Feskens EJ. The Dutch Healthy Diet index (DHD-index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutrition Journal 2012 11 49. (doi:10.1186/1475-2891-11-49)
16. Westerterp KR, SarisWH, Bloemberg BP, Kempen K, Caspersen CJ & Kromhout D. Validation of the Zutphen physical activity questionnaire for the elderly with double labeled water [abstract]. Medicine and Science in Sports andExercise199224S68. (doi:10.1249/00005768-199205001-00404)
17. Mickey RM & Greenland S. The impact of confounder selection criteria on effect estimation. American Journal of Epidemiology 1989 129 125-137.
18. Hernan MA, Robins JM. Causal inference 2014. Date last accessed: 02.09.2014. Available from: http://www.hsph.harvard.edu/wpcontent/uploads/sites/1268/2014/05/hernanrobins-v1.10.25.pdf
19. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism 2011 96 53-58. (doi:10.1210/jc.2010-2704)
20. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic Proceedings 2006 81 353-373. (doi:10.4065/81.3. 353)
21. HolickMF. Vitamin D status: measurement, interpretation, and clinical application. Annals of Epidemiology 2009 19 73-78. (doi:10.1016/j. annepidem.2007.12.001)
22. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL & Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011 59 1-8.
23. Reis JP, von Muhlen D & Miller ER III. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. European Journal of Endocrinology 2008 159 41-48. (doi:10.1530/ EJE-08-0072)
24. Hypponen E, Boucher BJ, Berry DJ & Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008 57 298-305. (doi:10.2337/db07-1122)
25. Hypponen E & Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006 29 2244-2246. (doi:10.2337/dc06-0946)
26. Kazlauskaite R, Powell LH, Mandapakala C, Cursio JF, Avery EF & Calvin J. Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women. Journal of Clinical Lipidology 2010 4 113-119. (doi:10.1016/j.jacl.2010.01.006)
27. John WG, Noonan K, Mannan N & Boucher BJ. Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. American Journal of Clinical Nutrition 2005 82 517-522.
28. Wehmeier KR, Mazza A, Hachem S, Ligaray K, Mooradian AD, Wong NC & Haas MJ. Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators. Biochimica et Biophysica Acta 2008 1780 264-273. (doi:10.1016/j.bbagen.2007.11.008)
29. Rye KA, Bursill CA, Lambert G, Tabet F & Barter PJ. The metabolism and anti-atherogenic properties of HDL. Journal of Lipid Research 2009 50 (Suppl) S195-S200. (doi:10.1194/jlr.R800034-JLR200)
30. Matsuura F, Wang N, Chen W, Jiang XC & Tall AR. HDL from CETPdeficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. Journal of Clinical Investigation 2006 116 1435-1442. (doi:10.1172/ JCI27602)
31. Zemel MB. Role of dietary calcium and dairy products in modulating adiposity. Lipids 2003 38 139-146. (doi:10.1007/s11745-003-1044-6)
32. Zemel MB. Role of calcium and dairy products in energy partitioning and weight management. American Journal of Clinical Nutrition 2004 79 907S-912S.
33. Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D & Kern PA. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. Journal of the American Society of Nephrology 1999 10 2158-2164.
34. Hajas A, Sandor J, Csathy L, Csipo I, Barath S, Paragh G, Seres I, Szegedi G, Shoenfeld Y & Bodolay E. Vitamin D insufficiency in a large MCTD population. Autoimmunity Reviews 2011 10 317-324. (doi:10.1016/j.autrev.2010.11.006)
35. Forman JP, Williams JS & Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010 55 1283-1288. (doi:10.1161/HYPERTENSIONAHA.109.148619)
36. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W & Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. Journal of Steroid Biochemistry and Molecular Biology 2004 89-90 387-392.
37. Leiter LA & Lewanczuk RZ. Of the renin-angiotensin system and reactive oxygen species type 2 diabetes and angiotensin II inhibition. American Journal of Hypertension 2005 18 121-128. (doi:10.1016/j. amjhyper.2004.07.001)
38. Wei Y, Sowers JR, Clark SE, LiW, Ferrario CM & Stump CS. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kB activation via NADPH oxidase. American Journal of Physiology. Endocrinology and Metabolism 2008 294 E345-E351. (doi:10.1152/ ajpendo.00456.2007)
39. Tai K, Need AG, Horowitz M & Chapman IM. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 2008 24 279-285. (doi:10.1016/j.nut.2007.11.006)